Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors.

DeFilipp Z, Rosand CB, Goldstein DA, Master VA, Carthon BC, Harris WB, Kucuk O, Al-Kadhimi Z, Cohen JB, Flowers CR, Lechowicz MJ, Nooka AK, Kaufman JL, Langston AA, Chen Z, Arora J, Waller EK.

Bone Marrow Transplant. 2017 Jan;52(1):132-134. doi: 10.1038/bmt.2016.189. Epub 2016 Jul 18. No abstract available.

PMID:
27427922
2.

Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma.

Harris WB.

Mol Aspects Med. 2015 Nov;45:47-54. doi: 10.1016/j.mam.2015.06.004. Epub 2015 Jun 10. Review.

PMID:
26071853
3.

Permissive hypertension during awake eversion carotid endarterectomy: a physiologic approach for cerebral protection.

LeSar CJ, Sprouse LR, Harris WB.

J Am Coll Surg. 2014 Apr;218(4):760-6. doi: 10.1016/j.jamcollsurg.2013.12.029. Epub 2014 Jan 5.

PMID:
24655867
4.

External validation of the modified Glasgow prognostic score for renal cancer.

Tai CG, Johnson TV, Abbasi A, Herrell L, Harris WB, Kucuk O, Canter DJ, Ogan K, Pattaras JG, Nieh PT, Master VA.

Indian J Urol. 2014 Jan;30(1):33-7. doi: 10.4103/0970-1591.124203.

5.

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.

Mahadevan D, Chiorean EG, Harris WB, Von Hoff DD, Stejskal-Barnett A, Qi W, Anthony SP, Younger AE, Rensvold DM, Cordova F, Shelton CF, Becker MD, Garlich JR, Durden DL, Ramanathan RK.

Eur J Cancer. 2012 Dec;48(18):3319-27. doi: 10.1016/j.ejca.2012.06.027. Epub 2012 Aug 23.

6.

Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy.

Cross BW, Johnson TV, Derosa AB, Ogan K, Pattaras JG, Nieh PT, Kucuk O, Harris WB, Master VA.

Int J Surg Oncol. 2012;2012:524981. doi: 10.1155/2012/524981. Epub 2012 Jul 29.

7.

Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.

Johnson TV, Ali S, Abbasi A, Kucuk O, Harris WB, Ogan K, Pattaras J, Nieh PT, Marshall FF, Osunkoya AO, Master VA.

J Urol. 2011 Oct;186(4):1213-7. doi: 10.1016/j.juro.2011.06.014. Epub 2011 Aug 17.

PMID:
21849188
8.

Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients.

Ali S, Yin-Goen Q, Johnson TV, Han W, Johnson NA, Harris WB, Marshall FF, Young AN, Master VA, Osunkoya AO.

Tumour Biol. 2011 Apr;32(2):375-80. doi: 10.1007/s13277-010-0130-9. Epub 2010 Nov 18.

PMID:
21086092
9.

Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma.

Johnson TV, Abbasi A, Owen-Smith A, Young AN, Kucuk O, Harris WB, Osunkoya AO, Ogan K, Pattaras J, Nieh PT, Marshall FF, Master VA.

Urology. 2010 Sep;76(3):766.e1-5. doi: 10.1016/j.urology.2010.01.052. Epub 2010 Apr 14.

PMID:
20394975
10.

Sleep/Wake patterns of individuals with advanced cancer measured by ambulatory polysomnography.

Parker KP, Bliwise DL, Ribeiro M, Jain SR, Vena CI, Kohles-Baker MK, Rogatko A, Xu Z, Harris WB.

J Clin Oncol. 2008 May 20;26(15):2464-72. doi: 10.1200/JCO.2007.12.2135.

PMID:
18487566
11.
12.

Current trends in molecular classification of adult renal tumors.

Young AN, Dale J, Yin-Goen Q, Harris WB, Petros JA, Datta MW, Wang MD, Marshall FF, Amin MB.

Urology. 2006 May;67(5):873-80. Review. No abstract available.

PMID:
16698345
13.

Proteomic analysis of proteins altered by dibenzoylmethane in human prostatic cancer LNCaP cells.

Frazier MC, Jackson KM, Jankowska-Stephens E, Anderson MG, Harris WB.

Proteomics. 2004 Sep;4(9):2814-21.

PMID:
15352255
14.

Neoadjuvant induction chemotherapy followed by chemoradiation: a phase I trial of gemcitabine, cisplatin, and 5-fluorouracil for advanced pancreatic/gastrointestinal malignancies.

Staley CA, Harris WB, Landry J, Small W, Kooby D, Gillespie TW, Meyers M, Bhalla KN.

Surg Oncol Clin N Am. 2004 Oct;13(4):697-709, x.

PMID:
15350943
15.

Dibenzoylmethane, a natural dietary compound, induces HIF-1 alpha and increases expression of VEGF.

Mabjeesh NJ, Willard MT, Harris WB, Sun HY, Wang R, Zhong H, Umbreit JN, Simons JW.

Biochem Biophys Res Commun. 2003 Mar 28;303(1):279-86.

PMID:
12646199
16.

Dibenzoylmethane induces cell cycle deregulation in human prostate cancer cells.

Jackson KM, DeLeon M, Verret CR, Harris WB.

Cancer Lett. 2002 Apr 25;178(2):161-5.

PMID:
11867200
17.

Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer.

Bhalla K, Harris WB.

Semin Oncol. 1998 Apr;25(2 Suppl 3):19-24. Review. No abstract available.

PMID:
9566203
18.

Effect of difluoromethylornithine on host and tumor polyamine metabolism during total parenteral nutrition.

Harris WB, Grossie VB, Ota DM, Nishioka K, Ajani JA, Chang T, Patenia D.

J Surg Res. 1985 Jun;38(6):592-8.

PMID:
3925242
19.

Starting from scratch.

Harris WB Jr.

J Natl Assoc Hosp Dev. 1976 Spring:17-9. No abstract available.

PMID:
10308965
20.

THE SIGNIFICANCE OF URINE URANIUM EXCRETION DATA.

LIPPMANN M, ONG LD, HARRIS WB.

Am Ind Hyg Assoc J. 1964 Jan-Feb;25:43-54. No abstract available.

PMID:
14115460

Supplemental Content

Loading ...
Support Center